Tekla Capital Management LLC Arrowhead Pharmaceuticals, Inc. Transaction History

Tekla Capital Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	SELL	$28.0 - $40.56 $1.58 Million - $2.29 Million	-56,453 Reduced 35.99%	100,422 $4.07 Million
Q2 2022 Jul 29, 2022	BUY	$27.79 - $50.61 $613,130 - $1.12 Million	22,063 Added 16.37%	156,875 $5.52 Million
Q4 2021 Feb 14, 2022	SELL	$58.09 - $82.51 $4.03 Million - $5.73 Million	-69,402 Reduced 33.98%	134,812 $8.94 Million
Q3 2021 Nov 12, 2021	BUY	$58.38 - $84.96 $4.16 Million - $6.06 Million	71,328 Added 53.68%	204,214 $12.7 Million
Q4 2020 Feb 12, 2021	BUY	$43.82 - $85.37 $2.57 Million - $5.01 Million	58,700 Added 79.13%	132,886 $10.2 Million
Q1 2020 May 14, 2020	SELL	$20.56 - $63.12 $641,718 - $1.97 Million	-31,212 Reduced 29.61%	74,186 $2.13 Million
Q4 2019 Feb 13, 2020	BUY	$28.14 - $73.01 $2.1 Million - $5.45 Million	74,698 Added 243.32%	105,398 $6.69 Million
Q4 2018 Feb 13, 2019	BUY	$10.74 - $19.7 $329,718 - $604,790	30,700 New	30,700 $381,000

295

91.1M

155K

426K

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $1.96B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

Get notified when there are updates to the investment portfolio of Tekla Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Tekla Capital Management LLC with notifications on news.